| Autor: |
Kameoka,Yosuke, Kishi,Fukuko, Koura,Minako, Yamakawa,Yoshio, Nagasawa,Rora, Ito,Fuyu, Matsuda,Junichiro, Suzuki,Osamu, Nakayama,Toshinori, Suzuki,Kazuo |
| Jazyk: |
angličtina |
| Rok vydání: |
2019 |
| Předmět: |
|
| Zdroj: |
Drug Design, Development and Therapy. |
| ISSN: |
1177-8881 |
| Popis: |
Kameoka Y, Kishi F, Koura M, et al. Drug Des DevelTher. 2019;13:555–568. The authors have advised that there was an error in the text. Page 561, beginning at the left-hand bottom of the page,“The number of peripheral blood lymphocytes and granulocytesdid not change in the aVAP2-administeredmice: WBCs: 4.42 (1.36–7.57)×109 cells/L vs 3.14(1.48–15.7)×109 cells/L (Figure S3A). The number ofgranulocytes decreased: 0.15 (0.05–1.04)×109 cells/L vs0.22 (0.04 0.69)×109 cells/L (Figure S3B).” shouldinstead read “The number of peripheral blood lymphocytesand granulocytes did not change in the aVAP2-administered mice: WBCs: 2.11 (1.36–2.44)×109 cells/Lvs 3.14 (1.48–15.7)×109 cells/L (Figure S3A). The numberof granulocytes decreased: 0.055 (0.03–0.08)×109 cells/Lvs 0.22 (0.04–0.69)×109 cells/L (Figure S3B).”Read the original article |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
